All News

2020

April

Media Release / Apr 02, 2020

Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program

Read More

March

Media Release / Mar 26, 2020

Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation

Read More
Media Release / Mar 24, 2020

AveXis presents AVXS-101 IT data demonstrating remarkable increases in HFMSE scores and a consistent clinically meaningful response in older patients with SMA Type 2

Read More
Media Release / Mar 20, 2020

Novartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response

Read More
Media Release / Mar 17, 2020

Novartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities

Read More
Media Release / Mar 03, 2020

International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa

Read More

February

Media Release / Feb 25, 2020

Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis

Read More
Media Release / Feb 11, 2020

Novartis announces MET inhibitor capmatinib (INC280), the first potential treatment for METex14 mutated advanced non-small cell lung cancer, granted priority FDA review

Read More

January

Novartis Campus Basel with buildings and a man biking
Featured News / Jan 29, 2020

Novartis 2019 Financial Results

Novartis announces the company’s fourth quarter and 2019 full year financial results.

Read More
Media Release / Jan 29, 2020

Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More